Clinical Trial Update: A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients [Phase 1]

View source ↗

Summary

A Phase 1 safety, pharmacokinetic and pharmacodynamic study of PUR0200 in COPD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PUR0200

Snippet

Sponsor: Pulmatrix Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED